Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intellectual developmental disorders: towards a new name, definition and framework for "mental retardation/intellectual disability" in ICD-11.
Salvador-Carulla L, Reed GM, Vaez-Azizi LM, Cooper SA, Martinez-Leal R, Bertelli M, Adnams C, Cooray S, Deb S, Akoury-Dirani L, Girimaji SC, Katz G, Kwok H, Luckasson R, Simeonsson R, Walsh C, Munir K, Saxena S. Salvador-Carulla L, et al. Among authors: cooray s. World Psychiatry. 2011 Oct;10(3):175-80. doi: 10.1002/j.2051-5545.2011.tb00045.x. World Psychiatry. 2011. PMID: 21991267 Free PMC article.
An international field study of the ICD-11 behavioural indicators for disorders of intellectual development.
Lemay KR, Kogan CS, Rebello TJ, Keeley JW, Bhargava R, Sharan P, Sharma M, Kommu JVS, Kishore MT, de Jesus Mari J, Ginige P, Buono S, Recupero M, Zingale M, Zagaria T, Cooray S, Roy A, Reed GM. Lemay KR, et al. Among authors: cooray s. J Intellect Disabil Res. 2022 Apr;66(4):376-391. doi: 10.1111/jir.12924. Epub 2022 Feb 16. J Intellect Disabil Res. 2022. PMID: 35170825
Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial.
Tyrer P, Oliver-Africano PC, Ahmed Z, Bouras N, Cooray S, Deb S, Murphy D, Hare M, Meade M, Reece B, Kramo K, Bhaumik S, Harley D, Regan A, Thomas D, Rao B, North B, Eliahoo J, Karatela S, Soni A, Crawford M. Tyrer P, et al. Among authors: cooray s. Lancet. 2008 Jan 5;371(9606):57-63. doi: 10.1016/S0140-6736(08)60072-0. Lancet. 2008. PMID: 18177776 Clinical Trial.
Problem behaviours and psychotropic medication use in intellectual disability: a multinational cross-sectional survey.
Perry BI, Cooray SE, Mendis J, Purandare K, Wijeratne A, Manjubhashini S, Dasari M, Esan F, Gunaratna I, Naseem RA, Hoare S, Chester V, Roy A, Devapriam J, Alexander R, Kwok HF. Perry BI, et al. Among authors: cooray se. J Intellect Disabil Res. 2018 Feb;62(2):140-149. doi: 10.1111/jir.12471. J Intellect Disabil Res. 2018. PMID: 29349928
Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: a randomised controlled trial (NACHBID).
Tyrer P, Oliver-Africano P, Romeo R, Knapp M, Dickens S, Bouras N, Ahmed Z, Cooray S, Deb S, Murphy D, Hare M, Meade M, Reece B, Kramo K, Bhaumik S, Harley D, Regan A, Thomas D, Rao B, Karatela S, Lenôtre L, Watson J, Soni A, Crawford M, Eliahoo J, North B. Tyrer P, et al. Among authors: cooray s. Health Technol Assess. 2009 Apr;13(21):iii-iv, ix-xi, 1-54. doi: 10.3310/hta13210. Health Technol Assess. 2009. PMID: 19397849 Free article. Clinical Trial.
Overcoming the barriers experienced in conducting a medication trial in adults with aggressive challenging behaviour and intellectual disabilities.
Oliver-Africano P, Dickens S, Ahmed Z, Bouras N, Cooray S, Deb S, Knapp M, Hare M, Meade M, Reece B, Bhaumik S, Harley D, Piachaud J, Regan A, Ade Thomas D, Karatela S, Rao B, Dzendrowskyj T, Lenôtre L, Watson J, Tyrer P. Oliver-Africano P, et al. Among authors: cooray s. J Intellect Disabil Res. 2010 Jan 1;54(1):17-25. doi: 10.1111/j.1365-2788.2009.01195.x. Epub 2009 Jul 21. J Intellect Disabil Res. 2010. PMID: 19627427 Clinical Trial.
89 results